Form 8-K - Current report:
SEC Accession No. 0000950170-24-102851
Filing Date
2024-09-03
Accepted
2024-09-03 16:30:09
Documents
11
Period of Report
2024-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cue-20240828.htm   iXBRL 8-K 55744
  Complete submission text file 0000950170-24-102851.txt   192042

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20240828.xsd EX-101.SCH 44883
13 EXTRACTED XBRL INSTANCE DOCUMENT cue-20240828_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 241274501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)